[#item_full_content]U.S. Treasury Secretary Janet Yellen wrapped up the fourth and final full day of her trip…
Category: Finance
Financial Health, Fintech, Investment, Payments
Imagination’s New Catapult CPU Is Driving RISC-V Device Adoption
[#item_full_content]LONDON–(BUSINESS WIRE)–Imagination Technologies today unveils the next product in the Catapult CPU IP range, the Imagination…
Ripple CEO predicts crypto market will double in size to $5 trillion by the end of 2024
[#item_full_content]Ripple CEO Brad Garlinghouse said he expects the entire value of the crypto market to double…
New ETF looks to profit from municipal bonds
[#item_full_content]BondBloxx aims to maximize after-tax returns with its new ETF, the IR+M Tax-Aware Short Duration ETF…
New ETF looks to profit from municipal bonds
[#item_full_content]BondBloxx aims to maximize after-tax returns with its new ETF, the IR+M Tax-Aware Short Duration ETF…
Fed Governor Bowman says additional rate hike could be needed if inflation stays high
[#item_full_content]Bowman said that it’s possible more hikes could be needed, rather than the cuts the market…
Fed Governor Bowman says additional rate hike could be needed if inflation stays high
[#item_full_content]Bowman said that it’s possible more hikes could be needed, rather than the cuts the market…
Here are some big money blind spots you need to avoid, advisors say
[#item_full_content]Here are some important aspects of personal finance you may be overlooking.
Free trade flaws fueled Trump’s rise in 2016 — and the problems remain, top economist says
[#item_full_content]Decades of trade deficits and a strong dollar created too many “losers” in the U.S. economy…
Free trade flaws fueled Trump’s rise in 2016 — and the problems remain, top economist says
[#item_full_content]Decades of trade deficits and a strong dollar created too many “losers” in the U.S. economy…
China’s Nio to expand battery swap services to gain an edge on EV infrastructure
[#item_full_content]Battery swapping takes only a few minutes and is expected to better address consumers’ driving range…
‘Biggest mistake’ bond investors may make ahead of Fed rate cuts
[#item_full_content]Experts advise taking advantage of opportunities in fixed income while yields are still high.
Here are some big money blind spots you need to avoid, advisors say
[#item_full_content]Here are some important aspects of personal finance you may be overlooking.
The Winners Circle Introduces Skill2Earn to Horse Racing
[#item_full_content]HONG KONG–(BUSINESS WIRE)– #Skill2Earn–The Winners Circle Introduces Skill2Earn to Horse Racing.
Here’s who Treasury Secretary Janet Yellen is going to meet in China
[#item_full_content]U.S. Treasury Secretary Janet Yellen was scheduled to arrive in China on Thursday ahead of four…
KKR says China’s real estate correction may only be halfway done
[#item_full_content]China’s real estate troubles are likely far from over and industry problems need to be addressed…
Fed’s Powell emphasizes need for more evidence that inflation is easing before cutting rates
[#item_full_content]Federal Reserve Chairman Jerome Powell said Wednesday it will take a while for policymakers to evaluate…
Fed’s Powell emphasizes need for more evidence that inflation is easing before cutting rates
[#item_full_content]Federal Reserve Chairman Jerome Powell said Wednesday it will take a while for policymakers to evaluate…
コンフォメーション・X・セラピューティクス、ステルス状態から脱却し、1350万ドル以上の資金調達で革新的な免疫腫瘍学パイプラインを推進
[#item_full_content]米マサチューセッツ州カントン–(BUSINESS WIRE)–(ビジネスワイヤ) — 免疫腫瘍分野に特化した医薬品開発企業であるコンフォメーション・X・セラピューティクスは、365万ドルの資金調達を完了し、創業以来の調達総額が1,350万ドルを超えたと発表しました。同社は、HHLA2およびIL18BPプログラムについて、ex vivoおよびin vivoでの概念実証試験に成功し、がん治療薬開発プロセスにおける重要なマイルストーンとなることを明らかにすることにより、同社の主要な資産を公開しました。 コンフォメーション・Xは、疾患生物学と薬効におけるタンパク質の立体構造の基本的な役割から発想を得て、新規免疫チェックポイント阻害剤の開発において比類ない精度を実現しています。同社は、既存の治療法では克服できなかったがんメカニズムに対処する、差別化された治療薬の包括的ポートフォリオを構築しています。 「現在のチェックポイント療法の限界は明らかで、非反応性や治療抵抗性に関連する多様なメカニズムを完全には標的にしていません」と、コンフォメーション・X・セラピューティクスのCEOであるアリ・H
Conformation-X Therapeutics sai do sigilo, garantindo mais de US$ 13,5 milhões em financiamento para impulsionar seu inovador pipeline de imuno-oncologia
[#item_full_content]CANTON, Massachusetts–(BUSINESS WIRE)–A Conformation-X Therapeutics, LLC, uma empresa de desenvolvimento de medicamentos com foco em imuno-oncologia,…